TargetMol

Sudoterb free base

Product Code:
 
TAR-T3480
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T3480-1mg1mg£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3480-2mg2mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3480-5mg5mg£197.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3480-10mg10mg£254.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3480-25mg25mg£342.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3480-50mg50mg£470.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3480-100mg100mg£653.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Sudoterb, also known as LL3858, is an anti-tubercular drug candidate.
CAS:
676266-31-2
Formula:
C29H28F3N5O
Molecular Weight:
519.572
Pathway:
Membrane transporter/Ion channel
Purity:
0.9885
SMILES:
Cc1c(CN2CCN(CC2)c2cccc(c2)C(F)(F)F)cc(-c2ccccc2)n1NC(=O)c1ccncc1
Target:
ATPase

References

LL-3858. Tuberculosis (Edinb). 2008 Mar;88(2):126. Respirology. 2010 Jul;15(5):764-78. doi: 10.1111/j.1440-1843.2010.201775.x. Epub 2010 Jun 4. Didilescu C, Craiova UM. [Present and future in the use of anti-tubercular drugs]. Pneumologia. 2011 Oct-Dec;60(4):198-201.